Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature

INTRODUCTION: Pharmacological therapy is recommended as a second-line alternative to reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. The aim of this paper is to investigate the pharmacoeconomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yan, Zou, Huimin, Ruan, Zhen, Chen, Xianwen, Lai, Yunfeng, Yao, Dongning, Ung, Carolina Oi Lam, Hu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658190/
https://www.ncbi.nlm.nih.gov/pubmed/38027186
http://dx.doi.org/10.3389/fendo.2023.1254398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658190/
https://www.ncbi.nlm.nih.gov/pubmed/38027186
http://dx.doi.org/10.3389/fendo.2023.1254398

Ejemplares similares